Mon, Jan 26, 2015, 12:02 PM EST - U.S. Markets close in 3 hrs 58 mins

Recent

% | $
Quotes you view appear here for quick access.

Fortinet Inc. Message Board

neelsen01 6 posts  |  Last Activity: 15 hours ago Member since: Feb 13, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • I think it's important to examine the reasons for investing in Agenus. I own 16450 shares at just under $6 and if Agenus spiked to $12 tomorrow I wouldn't sell. The vaccines that have benefited from their technology (anti-malarial and shingles) will provide a base income to justify a $12 stock price over the next two years. But I plan on holding the stock for at least six years to allow enough time for human trials to progress in their cancer vaccine pursuits. If even one type of cancer is controlled or destroyed during late trials with these new vaccines, we could be looking at a $500 dollar stock.. That's not a pie in the sky assessment. This company has the potential to skyrocket with even potential success in cancer vaccine development. If you're just trying to trade the stock for a quick gain be prepared to wait until news from the malaria vaccine being approved and/or GSK's shingles vaccine being filed for approval for a major jump in the stock. I plan on buying through the downturn up to my initial price. You will have to have a certain amount of patience with this company. We know the money is coming in with the two vaccines, so there's no reason to sell at these prices or even lower. This company will be worth at least $12 as these vaccines come to market over the next two years so why sell during the downturn?

    Sentiment: Strong Buy

  • agen could rally to 7 by May given momentum of news/potential earnings.

    Sentiment: Buy

  • Reply to

    Does AGEN really have substance ?

    by annasaaru Jan 14, 2015 2:48 PM
    neelsen01 neelsen01 Jan 14, 2015 7:14 PM Flag

    current vaccine last for at least three years. cdc doesn't currently recommend a booster. I would have to look at gsk studies to see how long their vaccine lasts. I suspect doctors would recommend a booster at ten years to make sure the virus remains dormant as long as the side effects remain minimal. it sure beats getting shingles! but since gsk's vaccine is given in two separate doses, their may be a reluctance to get a booster if recommended.

    Sentiment: Hold

  • Reply to

    Does AGEN really have substance ?

    by annasaaru Jan 14, 2015 2:48 PM
    neelsen01 neelsen01 Jan 14, 2015 6:57 PM Flag

    yes this stock has substance. I work in the medical field. a shingles vaccine that has 97.2% efficacy with minor side effects covering 16000 people will become the standard in preventing shingles. everyone that had chicken pox will be advised to get the vaccine after age 50. that will be over a billion in sales a year with agenus receiving perhaps 20-30million a year in royalties minimum year after year. and that is only one vaccine. they are working in other areas that may tempt a larger biotech company to acquire it.

    Sentiment: Hold

  • Be ready to tolerate a move down to 4.50. Don't sell however because the approval of GSK's shingles vaccine in 2015-2016 could push the stock over 10 very quickly.

    Sentiment: Hold

  • neelsen01 by neelsen01 Nov 21, 2014 8:05 AM Flag

    China's rate cut should spur consumer demand. LAS should benefit, at least in the short term.

    Sentiment: Hold

FTNT
32.23+0.30(+0.94%)12:02 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.